1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one

C24H28N2O2 — CID 90883448

IUPAC1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one
SMILESO=c1n(Cc2ccccc2)c(CCc2ccccc2)c(O)n1C1CCCCC1
InChIInChI=1S/C24H28N2O2/c27-23-22(17-16-19-10-4-1-5-11-19)25(18-20-12-6-2-7-13-20)24(28)26(23)21-14-8-3-9-15-21/h1-2,4-7,10-13,21,27H,3,8-9,14-18H2
InChIKeyJAPISNPJWWHNDV-UHFFFAOYSA-N
MW376.50 g/mol
LogP4.69
Rot. Bonds6

About 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one

1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one (PubChem CID 90883448) has the molecular formula C24H28N2O2 and a molecular weight of 376.50 g/mol. Its IUPAC name is 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one.

Molecular Properties

Compound Name1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one
PubChem CID90883448
Molecular FormulaC24H28N2O2
Molecular Weight376.50 g/mol
Exact Mass376.22
IUPAC Name1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one
SMILESO=c1n(Cc2ccccc2)c(CCc2ccccc2)c(O)n1C1CCCCC1
InChIInChI=1S/C24H28N2O2/c27-23-22(17-16-19-10-4-1-5-11-19)25(18-20-12-6-2-7-13-20)24(28)26(23)21-14-8-3-9-15-21/h1-2,4-7,10-13,21,27H,3,8-9,14-18H2
InChIKeyJAPISNPJWWHNDV-UHFFFAOYSA-N
XLogP4.69
TPSA47.16 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500376.50
LogP ≤ 54.69
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-cyclohexyl-6-hydroxy-1-(2-phenylethyl)pyrimidine-2,4-dione
CID 91386998
2-[4-[(3-cyclohexyl-4-methyl-2-oxo-5-propylimidazol-1-yl)methyl]phenyl]benzoic acid
CID 19740525
6-benzyl-7-hydroxy-3-methyl-1,3-dihydroimidazo[1,5-c][1,3]thiazol-5-one
CID 54391912
2-[4-[(5-butyl-3-cyclohexyl-4-fluoro-2-oxoimidazol-1-yl)methyl]phenyl]benzoic acid
CID 19741614
2-[4-[[3-cyclohexyl-4-methyl-5-(3-methylbutyl)-2-oxoimidazol-1-yl]methyl]phenyl]benzoic acid
CID 19740980
2-[4-[[3-cyclohexyl-4-(difluoromethyl)-5-(3-methylbutyl)-2-oxoimidazol-1-yl]methyl]phenyl]benzoic acid
CID 19741512
7-benzyl-9-cyclopentyl-6-phenoxypurin-8-one
CID 73293163
3-[3-cyclopentyl-5-hydroxy-2-oxo-1-(1-phenyl-3-sulfanylpropan-2-yl)imidazol-4-yl]propanoic acid
CID 54437381
1-benzyl-3-[1-(1-phenylcycloheptyl)piperidin-4-yl]benzimidazol-2-one
CID 18465448
1-(2-phenylethyl)-3-piperidin-4-ylbenzimidazol-2-one
CID 154396127
1-benzyl-4-cyclohexylpiperazine;oxalic acid
CID 126476719
2-cyclopentyl-5-(2-phenylethyl)-4H-pyrazol-3-one
CID 167833084

Frequently Asked Questions

What is the IUPAC name of 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one?
The IUPAC name of 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one (CID 90883448) is 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one.
What is the SMILES notation for 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one?
The canonical SMILES for 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one is O=c1n(Cc2ccccc2)c(CCc2ccccc2)c(O)n1C1CCCCC1.
What is the InChIKey of 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one?
The InChIKey is JAPISNPJWWHNDV-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H28N2O2/c27-23-22(17-16-19-10-4-1-5-11-19)25(18-20-12-6-2-7-13-20)24(28)26(23)21-14-8-3-9-15-21/h1-2,4-7,10-13,21,27H,3,8-9,14-18H2.
What are the key properties of 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one?
1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one has a molecular weight of 376.50 g/mol, XLogP of 4.69, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-benzyl-3-cyclohexyl-4-hydroxy-5-(2-phenylethyl)imidazol-2-one is sourced from PubChem (CID 90883448), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).